Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorVanderbilt-Ingram Cancer Center

About this trial

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer.

PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of non-small cell lung cancer

Clinical stage I and II disease

Resectable disease and complete surgical resection planned

Treated on companion studies at Vanderbilt University, the Veterans Administration hospital, St. Thomas, and Vanderbilt-Ingram Cancer Center Affiliate Network

Disqualifiers

Chemotherapy before surgery

Radiotherapy before surgery

Trial population

People who have clinical stage I and II non-small cell lung cancer

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • gene expression analysis

    Genetic

    Blood and lung tissue collection

  • microarray analysis

    Genetic

    Blood and lung tissue collection

  • protein expression analysis

    Genetic

    Blood and lung tissue collection

  • biologic sample preservation procedure

    Other intervention

    Blood and lung tissue collection

  • laboratory biomarker analysis

    Other intervention

    Blood and lung tissue collection

  • matrix-assisted laser desorption/ionization time of flight mass spectrometry

    Other intervention

    Blood and lung tissue collection

Treatment groups

4,000 Participants
are divided into 1 treatment group
Group A: Resectable non-small cell lung cancer6 interventions

Trial outcomes

Primary outcomes

1

Protein and RNA expression fingerprints from collected samples

Time frame
after collection of designated samples

Secondary outcomes

1

Development of statistical and computational methods to model relationship of data and clinical outcomes

Time frame
after laboratory gene analysis work is completed
2

Correlation of protein and RNA expression fingerprints with recurrence (local and/or distant) and survival

Time frame
after collection of designated samples

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Vanderbilt-Ingram Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator